More than 230 million adults in China suffering from hypertension, a modifiable risk factor, will be able to reduce their risk of heart attack now that medtech company Uscom (ASX: UCM) has had the BP+ device approved for sale by Chinese regulators. Installed on the International Space Station, the BP+ is a patent-protected device that
Read More
To assist with maintenance of ventilator devices being used to combat the coronavirus pandemic, Uscom (ASX: UCM) has released the SpiroSonic VENTITEST ventilator testing device which will allow medical professionals to calibrate ventilators, making it the first digital ultrasonic calibrator of its kind. With the need for ventilators having risen dramatically as the world grapples
Read More